Clinical Trial Update: Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating bronchopulmonary function response to azithromycin in chronic lung disease associated with HIV infection in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Lung Disease

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Chronic Lung Disease, HIV Infection | Phase 3 | Status: COMPLETED